• AAPL 167.04
  • TSLA 149.9
  • AMZN 179.17
  • MSFT 404.33
  • INTC 35.04
  • EURUSD 1.0651
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. EVAX.NASDAQ

Evaxion Biotech AS (EVAX NASDAQ) stock market data APIs

$4.11 -0.11(-2.6%) as of April 18, 2024

Evaxion Biotech AS Financial Data Overview

4.22
4.11
-
4.2482
4.11
2.8243-18.5
21 434 K
5 215 K
73 000
-1.6
-0.016
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EVAX',
Type: 'Common Stock',
Name: 'Evaxion Biotech AS',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1828253',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-02-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Evaxion Biotech AS Fundamental Data is available in our Financial Data APIs

  • Net Revenue 73 000
  • EBITDA -21 798 000
  • Earnings Per Share -8.1
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Evaxion Biotech AS Earnings via APIs

  • Latest Release 2024-03-26
  • EPS/Forecast -1.6

Get Evaxion Biotech AS End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Evaxion Biotech AS latest news via APIs

Evaxion va lever le voile sur un concept potentiellement révolutionnaire de vaccin précis contre le cancer alimenté par sa plateforme IA-Immunology™

Étude de validation : La plateforme IA-Immunology™ développée par Evaxion démontre une conception réussie de vaccins ciblés contre les formes de cancer du sang par le ciblage d’une nouvelle...
  • CALENDAR OF EVENTS
  • EVAXION BIOTECH
  • NASDAQ:EVAX
  • PRODUCT / SERVICES ANNOUNCEMENT

Evaxion stellt potenziell bahnbrechendes Konzept für AI-Immunology™-gestützen Präzisions-Krebsimpfstoff vor

Proof of Concept – Die AI-Immunology™-Plattform von Evaxion ist erfolgreich bei der Entwicklung von Präzisions-Krebsimpfstoffen für hämatologische Krebserkrankungen, die auf eine neue Klasse vo...
  • CALENDAR OF EVENTS
  • PRODUCT / SERVICES ANNOUNCEMENT
Do you have any questions?
support@eodhistoricaldata.com